Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine-cisplatin: A prospective observational cohort study
Hepatology, Dec 19 2025, | https://doi.org/10.1097/HEP.0000000000001650
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
J. Immunother. Cancer, Oct 05 2025, 13 (10) e010975 | https://doi.org/10.1136/jitc-2024-010975
Prognostic Significance of Volumetric Parameters on Pretreatment FDG PET/CT in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Therapy